Phase II Trial GA101 Inbrutinib B CLL

Clinical trial NCT02666898 · COMPLETED

Trial details

NCT number: NCT02666898
Sponsor: French Innovative Leukemia Organisation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Lymphocytic, Chronic, B-Cell

Start date: 2015-10-01
Primary completion: 2017-05-01
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.